Elsevier

Heart Rhythm

Volume 8, Issue 3, March 2011, Pages 480-483
Heart Rhythm

Hands-on
Implantable cardioverter-defibrillators in congenital heart disease: 10 programming tips

https://doi.org/10.1016/j.hrthm.2010.10.046Get rights and content

Introduction

Advances in cardiac care of the young have given rise to a growing and aging population of patients with congenital heart disease. Despite remarkable improvements in overall survival, sudden cardiac death remains the most common cause of late mortality. As a result, implantable cardioverter-defibrillators (ICDs) are increasingly used in this heterogeneous patient population. Tetralogy of Fallot and transposition of the great arteries are the most prevalent subtypes of congenital heart disease in ICD recipients.1, 2, 3 Common to this young population is the high rate of lead-related complications and inappropriate shocks.1, 2, 3 In a multicenter study of patients with tetralogy of Fallot, 25% received inappropriate shocks, predominantly due to sinus or supraventricular tachycardia.1 Although a similar proportion of patients with transposition received inappropriate shocks (24%), 62% were due to oversensing or lead dysfunction.3 Herein, we offer 10 practical tips for optimizing ICD programming in patients with congenital heart disease (Table 1) in view of reducing inappropriate and potentially avoidable shocks.

Section snippets

Faster cutoff rates

In ICD recipients in general, ventricular tachyarrhythmias typically are faster in patients with primary compared to secondary prevention indications, averaging 200 bpm versus 150 to 160 bpm, respectively.4 Because supraventricular tachycardia (SVT) generally ranges between 160 and 180 bpm, the ventricular fibrillation (VF) zone is often programmed between 182 and 188 bpm in patients with primary prevention ICDs at large. One could argue, however, that a higher cutoff rate (e.g., 200 bpm) would

Monitoring zones

Monitoring zones may detect slow VT and asymptomatic atrial arrhythmias, which are common in patients with surgically corrected congenital heart disease. With the exception of Sorin devices, monitoring zones are free from interactions with active zones. Thus, in contemporary ICDs, there is no major deterrent to programming monitoring zones. It should be noted, however, that if onset/stability discriminators are programmed in Guidant monitoring zones, discriminators are withheld in the active

Longer detection times

Programming ICDs for treatment of “sustained” ventricular tachyarrhythmias entails a compromise between overtreating otherwise self-terminating events and delaying therapy for potentially unstable arrhythmias. Whereas earlier ICD trials required 12 of 16 intervals to detect VF, longer detection times subsequently have been advocated.5 This criterion was later extended to 18 of 24 intervals, with no increase in adverse events. The safety of programming 30 of 40 intervals to detect VF was

Fast VT zones to allow antitachycardia pacing

Solid evidence now supports antitachycardia pacing (ATP) as a painless and effective therapy to terminate VT. In patients with congenital heart disease, ATP as the first appropriate therapy was successful in 79% of cases.1, 3 Randomized clinical trials in noncongenital patients have indicated no increased rate of syncope, death, or VT acceleration.6 More recent studies compared a standardized single ATP sequence in the fast VT zone with physician-tailored programming.7, 8 Significantly fewer

Rate smoothing

Rate smoothing reduces the maximum variation in cycle length by a programmable value. It is available in Guidant/Boston, Medtronic, and Sorin devices. By minimizing short–long–short intervals, rate smoothing was developed to reduce the ventricular arrhythmia burden. Although the impact of rate smoothing has not been assessed in congenital heart disease, initial studies suggested benefit in patients with long QT syndrome.12 However, subsequent case reports have cautioned against underdetection

Avoid or extend “high rate time out/sustained rate duration”

“High rate time out” and “sustained rate duration” are timers to override discriminators. Once the timer elapses, therapy is delivered even if it had been appropriately withheld. Designed as a safety feature in the event that VT is misclassified as SVT, these timers are an important source of inappropriate shocks because SVT episodes often last longer than the duration of the timer.11 Moreover, the literature suggests that this safety feature is of little value, with no reported adverse events

ATP in VF zone when available

The weight of evidence suggests that at least one ATP sequence should be programmed for VTs between 188 and 250 bpm and that two sequences are superior to one. ATP for VT faster than 250 bpm appears safe, albeit less effective. Medtronic ATP during charging can be activated for rhythms over 250 bpm. ATP during charging currently is not available in St. Jude devices but will be integrated in recently approved Fortify ICDs. Boston's Quickconvert delivers one ATP sequence in the VF zone before

Number of ATP sequences (at least 2 in faster VT zones and 4–6 in slower VT zones)

In fast VT zones, the success rate with two ATP sequences is superior to one, with the second terminating 35% of VTs. For induced VTs faster than 250 bpm, a 30% success rate was noted with up to 6 ATP sequences.15 Although rate acceleration occurred in 24%, all shocks ultimately were successful. Programming ATP for VT slower than 180 bpm is common practice, but evidence-based strategies (e.g., number of sequences and stimuli, burst versus ramp) are scarce. One study compared four settings:

Shock output

To our knowledge, no study has specifically compared incremental versus high-energy shocks. Advantages of low-energy shocks include shorter charge times, extended battery life, and possibly less myocardial damage. Nevertheless, in the modern era, charge time is not a major issue, and higher-energy shocks carry a greater probability of success. Additional advantages of high-energy shocks may include a higher probability of terminating inappropriately treated SVTs (for which the shock vector is

Conclusion

Although carefully selected patients with congenital heart disease undoubtedly are benefitting from ICDs, enthusiasm for this potentially lifesaving therapy is tempered by the high rate of complications. Encouragingly, many inappropriate or unnecessary distressful shocks may be prevented by tailored ICD programming. The one-zone “shock box” approach should be considered obsolete in light of the growing body of evidence demonstrating the safety and superiority of alternate strategies to reduce

First page preview

First page preview
Click to open first page preview

References (17)

There are more references available in the full text version of this article.

Cited by (23)

View all citing articles on Scopus

This work was supported in part by the Canada Research Chair in Electrophysiology and Adult Congenital Heart Disease (PK). Dr. Mansour has served as a consultant for Biotronik.

View full text